Pharmacy Times^® Clinical Forum events are roundtable discussions in specific therapeutic areas led by specialized practitioners and designed to share their real-world experiences and best practices. Pharmacy Times recaps discussions and creates articles and content to be featured in Pharmacy Times print publications and on pharmacytimes.com.

Meeting Objectives:

• Examine the primary role of GLP-1 receptor agonists in improving glycemic control, with an emphasis on A1c reduction, glucose variability, and delaying disease progression in patients with Type 2 diabetes. 

• Review evidence from key clinical trials and real-world studies supporting the use of GLP-1 receptor agonists for holistic diabetes care, including glycemic control, weight management, reduced insulin dependence, and effectiveness across diverse patient populations. 

• Examine the cardiovascular and renal protective effects of GLP-1 receptor agonists while addressing practical considerations for implementation, including patient selection, adherence, and access challenges. 

Attendees benefit by:

• Engaging with peers on scientific advancements, innovative treatment protocols, and effective patient management approaches.

• Discovering implementation strategies from leading institutions and centers of excellence that have transformed patient outcomes.

• Building valuable professional relationships with fellow specialists that extend beyond the event.